<DOC>
	<DOCNO>NCT00000388</DOCNO>
	<brief_summary>This trial continuation Multimodal Treatment Study Children Attention Deficit Hyperactivity Disorder ( MTA Study ) . Continuation Aim 1 track persistence intervention-related effect MTA sample mature mid-adolescence , include subsequent mental-health school-related service utilization pattern function MTA treatment experience ( treatment assignment ) outcome ( degree treatment success 14 mo. ) . Aim 2 test specific hypotheses predictor , mediator , moderator long-term outcome among child ADHD ( e.g. , comorbidity ; family functioning ; cognitive skill ; peer relation ) may influence adolescent functioning ( either independent initial treatment assignment and/or 14-month treatment outcome ) ; compare predictor , mediator , moderator similar dissimilar within normal comparison group . Aim 3 track pattern risk protective factor ( include mediation moderation initial treatment assignment and/or outcome ) involve early subsequent stage develop substance-related disorder antisocial behavior . Aim 4 examine effect initial treatment assignment degree treatment success later academic performance , achievement , school conduct , tendency drop , adverse school outcome . In original MTA design , patient randomly assign 1 4 treatment condition : ( 1 ) medication ; ( 2 ) psychosocial ; ( 3 ) combine ( medication psychosocial ) ; ( 4 ) Assessment-and-Referral condition . All latter treat intensively 14 month , assessment subject baseline , 3 , 9 , 14 , 24 month . The original MTA design thus provide short-term ( 10 month post-treatment ) follow-up 24 month . This continuation extend follow-up assessment 36 , 60 , 84 month treatment . A child may eligible study he/she : Is 7 - 9 year old , Attention Deficit Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>Multimodal Treatment Study Children With Attention Deficit Hyperactivity Disorder ( MTA )</brief_title>
	<detailed_description>This trial continuation Multimodal Treatment Study Children Attention Deficit Hyperactivity Disorder ( MTA Study ) . Continuation Aim 1 track persistence intervention-related effect MTA sample mature mid-adolescence , include subsequent mental-health school-related service utilization pattern function MTA treatment experience ( treatment assignment ) outcome ( degree treatment success 14 mo. ) . Aim 2 test specific hypotheses predictor , mediator , moderator long-term outcome among child ADHD ( e.g. , comorbidity ; family functioning ; cognitive skill ; peer relation ) may influence adolescent functioning ( either independent initial treatment assignment and/or 14-month treatment outcome ) ; compare predictor , mediator , moderator similar dissimilar within normal comparison group . Aim 3 track pattern risk protective factor ( include mediation moderation initial treatment assignment and/or outcome ) involve early subsequent stage develop substance-related disorder antisocial behavior . Aim 4 examine effect initial treatment assignment degree treatment success later academic performance , achievement , school conduct , tendency drop , adverse school outcome . In original MTA design , patient randomly assign 1 4 treatment condition : ( 1 ) medication ; ( 2 ) psychosocial ; ( 3 ) combine ( medication psychosocial ) ; ( 4 ) Assessment-and-Referral condition . All latter treat intensively 14 month , assessment subject baseline , 3 , 9 , 14 , 24 month . The original MTA design thus provide short-term ( 10 month post-treatment ) follow-up 24 month . This continuation extend follow-up assessment 36 , 60 , 84 month treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Antisocial Personality Disorder</mesh_term>
	<criteria>Patients must : Rigorously diagnose Attention Deficit Hyperactivity Disorder ( ADHD ) .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Attention Deficit Disorder Hyperactivity</keyword>
	<keyword>Adolescence</keyword>
	<keyword>Child</keyword>
	<keyword>Cognition</keyword>
	<keyword>Combined Modality Therapy</keyword>
	<keyword>Female</keyword>
	<keyword>Human</keyword>
	<keyword>Male</keyword>
	<keyword>Peer Group</keyword>
	<keyword>Risk Factors</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Attention Deficit Disorder Hyperactivity -- *therapy</keyword>
	<keyword>Attention Deficit Disorder Hyperactivity -- drug therapy</keyword>
	<keyword>Attention Deficit Disorder Hyperactivity -- psychology</keyword>
</DOC>